China’s WuXi Biologics has announced a 10-year investment plan aimed at establishing a world-class pharmaceutical contract manufacturing center in Singapore. The Singapore Economic Development Board (EDB) is supporting the project. EDB Chairman Dr Beh Swan Gin stated that “The investments will establish Singapore as a significant node in the company’s global research, development and manufacturing […]
Thank you for registering!
An account was already registered with this email. Please check your inbox for an authentication link.